NEW YORK, Aug. 23 - Ambion today said it has won a $1.6 million Phase II SBIR grant from the US National Institutes of Health to continue developing its RNA-amplification technology.
Ambion, of Austin, Texas, said it hopes its technology will enhance the enzymatic processes to improve DNA microarray results and ultimately help researchers advance DNA arrays by integrating them onto both robotic and microfluidic platforms.
Click here for more information.